Avantax Advisory Services’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
Avantax Advisory Services's EXAS Position: Q2 2025 in Review
Avantax Advisory Services reduced its Exact Sciences (EXAS) stake by 19% in Q2 2025, selling an estimated $61.9K and leaving 5,369 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #1951.
Avantax Advisory Services first reported a position in EXAS in Q3 2020 and has held it in 16 quarters since. The position peaked at $430K in Q3 2024. 558 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.
- Avantax Advisory Services held 5,369 shares of Exact Sciences worth $285K as of Q2 2025.
- Avantax Advisory Services sold 1,219 Exact Sciences shares in Q2 2025, an estimated $61.9K.
- Exact Sciences made up ﹤0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #1951 holding.
- Avantax Advisory Services first reported a position in Exact Sciences in Q3 2020 and has held it in 16 quarters since.
- Avantax Advisory Services's Exact Sciences position peaked at $430K in Q3 2024.
- 558 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.
Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.